Dr. Yan-Bo Yang has over 30 years of extensive experiences in chemical analysis and purification for small molecules and large biologics. Dr. Yang is an expert in chromatography theory, column technology, application development, and method development/validation. Dr. Yang is the founder and founding president (1st and 2nd terms, 2008-2012) of Chinese American Chromatography Association (CACA). Dr. Yang is one of the authors for the 1st published paper on Perfusion Chromatography and one of the inventors for the POROS® Chromatography Resins. Dr. Yang is the author of the 1st published paper discussing about the hydrophilic interaction separations. Dr. Yang founded BioPharmaDev, Inc.( www.biopharmadev.com) in 2012 providing chemical analysis and product development services for life-science industries. Before BioPharmaDev, Inc. Dr. Yang was Director at B. Braun Medical, responsible for all aspects of pharmaceutical developments. Prior to B. Braun, Dr. Yang was Director of Research at The Separations Group, Inc (Vydac), responsible for developing novel HPLC packing materials/columns and studying separation mechanisms using different chromatography methodologies.Dr. Yang serves as president and major leadership roles in multiple regulatory, policy-making and professional organizations, including Chair of the United States Pharmacopeia (USP) 2012 PNP Stakeholder Forum, Member of the USP PNP Stakeholder Forum Planning Committee, Project Team Member for the USP General Notices revisions, Member of the USP Plastics Working Group for implementation of new USP General Chapters on Extractables/Leachables, Member of USP-NF Online Customer Advisory Board, President of Southern California Section of AOAC International, Chair of AOAC ALACC Dietary Supplement Subcommittee.